228 related articles for article (PubMed ID: 8091766)
81. Bisphosphonates and primary hyperparathyroidism.
Rodan GA
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793
[TBL] [Abstract][Full Text] [Related]
82. Efficacy and Safety of Intravenous Pamidronate for Parathyroid Hormone-dependent Hypercalcemia in Hospitalized Patients.
Rosenblum RC; Twito O; Barzilay-Yoseph L; Ramaty E; Klein N; Rotman-Pikielny P
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4593-e4602. PubMed ID: 34157125
[TBL] [Abstract][Full Text] [Related]
83. Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy.
Thiébaud D; Portmann L; Jaeger P; Jacquet AF; Burckhardt P
Bone; 1986; 7(4):247-53. PubMed ID: 3768203
[TBL] [Abstract][Full Text] [Related]
84. Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
Ahrén B; Bergenfelz A
Horm Res; 1995; 43(6):294-9. PubMed ID: 7607615
[TBL] [Abstract][Full Text] [Related]
85. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
Massagli TL; Cardenas DD
Arch Phys Med Rehabil; 1999 Sep; 80(9):998-1000. PubMed ID: 10488998
[TBL] [Abstract][Full Text] [Related]
86. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
Ridefelt P; Gylfe E; Akerström G; Rastad J
Surgery; 1995 Jan; 117(1):56-61. PubMed ID: 7809837
[TBL] [Abstract][Full Text] [Related]
87. Effects of fasting, feeding, and bisphosphonate administration on serum calcitriol levels in phosphate-deprived rats.
Felsenfeld AJ; Jara A; Avedian G; Kleeman CR
Kidney Int; 2000 Sep; 58(3):1016-22. PubMed ID: 10972666
[TBL] [Abstract][Full Text] [Related]
88. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
[TBL] [Abstract][Full Text] [Related]
89. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
90. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.
Thürlimann B; Waldburger R; Senn HJ; Thiébaud D
Ann Oncol; 1992 Sep; 3(8):619-23. PubMed ID: 1450043
[TBL] [Abstract][Full Text] [Related]
91. 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study.
Bacchini G; Fabrizi F; Pontoriero G; Marcelli D; Di Filippo S; Locatelli F
Nephron; 1997; 77(3):267-72. PubMed ID: 9375818
[TBL] [Abstract][Full Text] [Related]
92. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
93. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
[TBL] [Abstract][Full Text] [Related]
94. Successful Use of Denosumab for Life-Threatening Hypercalcemia in a Pediatric Patient with Primary Hyperparathyroidism.
Mamedova E; Kolodkina A; Vasilyev EV; Petrov V; Belaya Z; Tiulpakov A
Horm Res Paediatr; 2020; 93(4):272-278. PubMed ID: 32998142
[TBL] [Abstract][Full Text] [Related]
95. One-shot high-dose pamidronate disodium (APD): effective, simple treatment for hypercalcaemia in haematological malignancy.
Sawyer N; Newstead C; Drummond A; Newland A; Cunningham J
Clin Lab Haematol; 1989; 11(3):179-84. PubMed ID: 2591149
[TBL] [Abstract][Full Text] [Related]
96. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
[TBL] [Abstract][Full Text] [Related]
97. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
98. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
Rajala MM; Klee GG; Heath H
J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
[TBL] [Abstract][Full Text] [Related]
99. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Young G; Shende A
Med Pediatr Oncol; 1998 Feb; 30(2):117-21. PubMed ID: 9403021
[TBL] [Abstract][Full Text] [Related]
100. Conventional treatment of hypercalcemia of malignancy.
Davidson TG
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
